Sui Xiong Cai

Company: IMPACT Therapeutics

Job title: Executive Vice President & Chief Technology Officer

Seminars:

Panel Discussion: A Comparison; The Challenges & Learnings of Developing ATR inhibitors – What Clinical Space Will They Occupy? 2:20 pm

Analyzing the current applications of these inhibitors both in preclinical and clinical studies either as single agents or in combinations with chemotherapy, radiotherapy and immunotherapy Dissecting toxicity profiles (bone marrow toxicity?) Opening the ATR inhibitor black box: what clinical space will they occupy? Understanding biomarker indications for ATR sensitivity: Cyclin E, ATM Loss? not as…Read more

day: Day One